Blood Market: Industry Share, Revenue, Growth, Analysis 2023Posted by Sandeep Salunkhe on April 5th, 2019 According to Allied Market Research the global blood market was valued at ,500 million in 2016, and is projected to reach ,982 million by 2023, registering a CAGR of 4.6% from 2017 to 2023. The blood therapeutics segment contributed the highest share in 2016, owing to the increase in the demand for various plasma proteins for the recovery of patients. The blood market products include whole blood collection, source plasma collection, blood therapeutics, blood typing products, blood screening, and blood processing equipment & associated products. Increase in geriatric population, rise in trauma cases, technological advancement in medical technology for donor screening, and advancement in blood transfusion instruments drive the market growth. However, rise in minimal invasive technology, which no longer require the blood transfusion hamper the market growth. Increase in peripheral nerve injuries and improvement in the healthcare facilities in Asia-Pacific provide growth opportunities for the market. Download Sample @ https://www.alliedmarketresearch.com/request-sample/2297?utm_source=openpr_ss Blood & blood component banks contributed the highest share in 2016, owing to the increase in the demand for using equipment for the blood processing and for segregation of the blood components. North America accounted for significant share in the global market in 2016, owing to an established healthcare industry and rise in number of patient population requiring blood & blood components. Major Market Players:
Key Findings of the Blood Market:
The major companies profiled in the report include Abbott Laboratories, Baxter International Inc., Becton, Dickinson & Co., CSL Behring, Immucor, Novartis, Novo Nordisk, Ortho Clinical Diagnostics, Roche Diagnostics, and Grifols International SA. Send Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/2297?utm_source=openpr_ss Like it? Share it! More by this author |